Blog
Onshoring in Life Sciences: Why the Talent Strategy Will Define the Winners
Over the past several years, the conversation around onshoring has moved from theory to action. Across the United States, pharmaceutical and biotechnology companies are breaking ground on new manufacturing facilities, expanding domestic supply chains, and rethinking how medicines are produced. From North Carolina to Texas to the Midwest, billions of dollars are being invested in infrastructure designed to bring critical ...


